Management Forum Logo

Presented by
Management Forum

In the Light of Annex 1: Use of Barrier Systems for Aseptic Pharmaceutical Manufacturing Training Course

This free webinar will familiarise attendees with Restricted Access Barrier System (RABS) technologies. An excellent opportunity to receive detailed information about barrier systems with a main focus on isolator technology, particularly since the implementation of EU GMP Annex 1.

6 March 2024 »

Need help?  Register now

  • Format: Live online
  • CPD: 1.5 hours for your records
  • Certificate of completion


The industry of aseptic pharmaceutical manufacturing, i.e. manufacturing companies as well as related equipment suppliers and engineering companies, have been pretty busy in evaluating the impact of the revised EU GMP guide Annex 1, which came into force on 25 August 2023.
Even before its release, Annex 1 has triggered many heated debates on how it will influence existing aseptic manufacturing processes. These debates have further intensified after publication in August 2022. On the one hand, some paragraphs leave a lot of room for interpretation. On the other hand, the industry fears over-regulation.
But what impact will the new EU GMP Annex 1 really have on sterile filling and processing operations? How will it change the way we work in the pharmaceutical industry? And which technologies are particularly suitable? 
One topic, addressed at the very beginning of the Annex 1 guideline in ''Chapter 2 Principle", is that "The use of appropriate technologies (e.g. Restricted Access Barriers Systems (RABS), isolators, robotic systems, rapid/alternative methods and continuous monitoring systems) should be considered to increase the protection of the product from potential extraneous sources of endotoxin/pyrogen, particulate and microbial contamination such as personnel, materials and the surrounding environment, and assist in the rapid detection of potential contaminants in the environment and the product."
This is a clear indication that Restricted Access Barrier Systems (RABS) or isolators should be used for new equipment to be installed in aseptic pharmaceutical manufacturing.
This webinar will familiarise attendees with barrier system technologies and discuss the complexities involved. 

This course is part of our GxP (Good x Practice) training course collection, which feature a variety of topic areas to ensure you comply with the regulations and quality guidelines.

Beneftis of Attending

By participating in this webinar, you will receive detailed information about barrier systems with a main focus on isolator technology.

  • Gain an overview of the justification for using barrier systems
  • Discover the differences between RABS and Isolators
  • Understand how an isolator is characterised
  • Learn the difference between aseptic and high potent isolators
  • Hear about isolator air management

Who Should Attend

Sterile Medicinal Product Manufacturers in the following departments:

  • Quality Assurance
  • Quality Control
  • Manufacturing
  • Aseptic Filling
  • Regulatory Affairs
  • Maintenance
  • Engineering

This webinar will also be of interest to:

  • Regulatory Authority Inspectors / Auditors
  • Pharmacy, chemistry, engineering students and new graduates

Register now

The In the Light of Annex 1: Use of Barrier Systems for Aseptic Pharmaceutical Manufacturing course will cover:

Background and Justification to use Barrier Systems

Differences Between RABS and Isolators (both Recommended by Annex 1)

Why use Isolators?

How is an Isolator Characterised?

  •    Isolator housing/process chamber
  •    Air management
  •    Bio-decontamination system

Differences Between Aseptic and High Potent Isolators

Isolator Air Management - Different Possibilities


Register now

Lukas Munzinger
Syntegon Technology GmbH

Lukas Munzinger started his career with an apprenticeship in 2001 with Bosch Packaging Technology to become an industrial technician for fill/finish packaging machinery. From 2007 until 2011 he finished his bachelor's degree in industrial engineering and business administration at the University of Applied Sciences in Karlsruhe, Germany. Since 2011 he was working in international sales for fill/finish equipment machinery with Syntegon (formerly Bosch Packaging Technology). His market responsibilities were mainly in Latin American countries, but he was also handling complex isolator projects around the globe. From 2017 to 2018 he worked as a Business Developer in Panama City, Panamá. Since December 2022 he has been the global product manager for Barrier Systems and Isolator Technology as well as Depyrogenation Tunnels at the Syntegon site in Crailsheim, Germany. Overall, Lukas has more than 12 years of experience in the primary packaging industry for pharmaceutical fill/finish lines and contributed to many successful customer projects and installations all over the world.

More details

Register for In the Light of Annex 1: Use of Barrier Systems for Aseptic Pharmaceutical Manufacturing

6 March 2024
14:00-15:30 UK (London) (UTC+00)
15:00-16:30 Paris (UTC+01)
09:00-10:30 New York (UTC-05)


If you already have an account with us, please log in first (or register); if not, just fill in your details below, and we'll send you details of the webinar right away:

* Access our free webinars and white papers when you register for email updates. We will keep you informed of new courses in your relevant subject area; you may unsubscribe at any time.

Please see our privacy policy to learn how we use the information you provide


  • Antibiotice
  • Antibiotice SA


  • Kaunas University of Technology

Saudi Arabia

  • Pharmacy student

Register now

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Training expert

+44 (0)20 7749 4749